Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1995 2
1996 2
1997 2
1998 4
1999 1
2000 2
2001 7
2002 8
2003 3
2004 5
2005 9
2006 8
2007 5
2008 10
2009 11
2010 14
2011 6
2012 7
2013 11
2014 11
2015 16
2016 17
2017 6
2018 10
2019 21
2020 23
2021 19
2022 8
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Acute Graft-Versus-Host Disease: A Brief Review.
Aladağ E, Kelkitli E, Göker H. Aladağ E, et al. Among authors: goker h. Turk J Haematol. 2020 Feb 20;37(1):1-4. doi: 10.4274/tjh.galenos.2019.2019.0157. Epub 2019 Sep 2. Turk J Haematol. 2020. PMID: 31475512 Free PMC article. Review.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ; QUAZAR AML-001 Trial Investigators. Wei AH, et al. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. N Engl J Med. 2020. PMID: 33369355 Clinical Trial.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group. Dimopoulos MA, et al. Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10. Lancet. 2019. PMID: 30545780 Clinical Trial.
Hypophosphatemia related to the use of ibrutinib.
Karadeniz M, Cinar OE, Erdogdu B, Malkan UY, Goker H, Ozcebe OI. Karadeniz M, et al. Among authors: goker h. J Oncol Pharm Pract. 2023 Mar 29:10781552231164504. doi: 10.1177/10781552231164504. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 36987737
Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center.
Göker H, Çınar OE, Demiroğlu H, Malkan ÜY, Aladağ Karakulak E, Büyükaşık Y. Göker H, et al. Turk J Haematol. 2023 Aug 31;40(3):213-215. doi: 10.4274/tjh.galenos.2023.2023.0089. Epub 2023 Jun 14. Turk J Haematol. 2023. PMID: 37314288 Free PMC article. No abstract available.
220 results